The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Sotac Pharmaceuticals's Dividend Payout Ratio for the
months ended in Sep. 2025 was 0.05.
The historical rank and industry rank for Sotac Pharmaceuticals's Dividend Payout Ratio or its related term are showing as below:
NSE:SOTAC'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0.01
Current: 0.01
During the past 6 years, the highest Dividend Payout Ratio of Sotac Pharmaceuticals was 0.01. The lowest was 0.00. And the median was 0.00.
NSE:SOTAC's Dividend Payout Ratio is ranked better than 99.78% of 445
companies
in the Drug Manufacturers industry
Industry Median: 0.38
vs NSE:SOTAC: 0.01
During the past 6 years, the highest Trailing Annual Dividend Yield of Sotac Pharmaceuticals was 0.10%. The lowest was 0.00%. And the median was 0.00%.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Sotac Pharmaceuticals (NSE:SOTAC) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Sotac Pharmaceuticals Dividend Payout Ratio Related Terms
Sotac Pharmaceuticals Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Sotac Pharmaceuticals's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SOTAC vs ZTS, UTHR: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Sotac Pharmaceuticals's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sotac Pharmaceuticals Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sotac Pharmaceuticals's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Sotac Pharmaceuticals's Dividend Payout Ratio falls into.
Sotac Pharmaceuticals Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Sotac Pharmaceuticals's Dividend Payout Ratio for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sotac Pharmaceuticals (NSE:SOTAC) has a Dividend Payout Ratio of 0.05 as of Sep. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Sotac Pharmaceuticals and its competitors. According to the industry distribution chart, Sotac Pharmaceuticals ranks #1 out of 445 companies in the Drug Manufacturers industry, placing it in the top 0.2%.
Is Sotac Pharmaceuticals' Dividend Payout Ratio too high?
Sotac Pharmaceuticals' current Dividend Payout Ratio is 0.05. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Sotac Pharmaceuticals' value of 0.05 is 86.8% below this industry median. Based on the distribution chart, Sotac Pharmaceuticals ranks #1 out of 445 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sotac Pharmaceuticals has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sotac Pharmaceuticals' Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sotac Pharmaceuticals ranks #1 out of 445 companies for Dividend Payout Ratio. This places Sotac Pharmaceuticals in the top 0% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.38. Sotac Pharmaceuticals' value of 0.05 is 86.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 445 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sotac Pharmaceuticals's current Dividend Payout Ratio of 0.05 is 86.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Sotac Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sotac Pharmaceuticals's current Dividend Payout Ratio is 0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sotac Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Sotac Pharmaceuticals (NSE:SOTAC) is currently considered Fairly Valued. The stock's GF Value™ is ₹110.01, compared to a current price of ₹101.00 — trading 8.2% below its estimated fair value. The current Dividend Payout Ratio is 0.05 and 86.8% below the Drug Manufacturers industry median of 0.38. Sotac Pharmaceuticals' overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Sotac Pharmaceuticals (NSE:SOTAC), the current Dividend Payout Ratio is 0.05 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sotac Pharmaceuticals (NSE:SOTAC) Overvalued in 2026?
Based on GuruFocus' analysis, Sotac Pharmaceuticals stock appears to be undervalued.
The current stock price of ₹101.00 is trading 8.2% below its estimated GF Value™ of ₹110.01.
GuruFocus considers Sotac Pharmaceuticals to be Fairly Valued.
Key valuation signals for NSE:SOTAC:
Dividend Payout Ratio: 0.05
GF Value™: ₹110.01 vs. price of ₹101.00 (8.2% below fair value)
Industry Position: 86.8% below the Drug Manufacturers median (#1 of 445)
No single metric tells the full story. See the NSE:SOTAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sotac Pharmaceuticals Ltd operates chiefly in pharmaceutical manufacturing, serving a broad range of therapeutic segments including anti-diabetic, anti-psychotic, vitamins and minerals, anti-cold, anti-allergic, derma products, antacids, anti-ulcerants, cardiac, analgesic, anti-bacterial, anti-fungal, and more. The company manufactures tablets, capsules, syrups, and external preparations under contract manufacturing and loan licensing agreements, for domestic and international markets. Its clients include notable pharmaceutical marketers such as Cadila Pharma and Viatris. Revenue is distributed between domestic pharmaceutical product sales and international exports, supporting scalable growth across geographies.
56GF Score
Get the complete analysis for NSE:SOTAC
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SOTAC has been successfully added to your 
